FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

373308008: Local anti-infective (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1198606016 Local anti-infective (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211795018 Local anti-infective en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1229204010 Local antiseptic en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1198606016 Local anti-infective (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1198606016 Local anti-infective (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211795018 Local anti-infective en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1211795018 Local anti-infective en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1229204010 Local antiseptic en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1229204010 Local antiseptic en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Local anti-infective Is a Anti-infective agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Local anti-infective Is a agent cutané false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Benzocaine 10 mg/mL and triclosan 2 mg/mL cutaneous spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzocaine+triclosan 1/0.2% cream (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Econazole nitrate 10 mg/g and hydrocortisone 10 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Ichthammol 10% ointment BP The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Zinc+ichthammol cream BP The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide+potassium hydroxyquinoline sulfate 10/0.5% cream (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide+potassium hydroxyquinoline sulfate 5/0.5% lotio-gel (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Tetracycline hydrochloride 2.2 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzoyl peroxide 40 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 50 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 10% gel (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 2.5% aqueous gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 5% aqueous gel (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 10% aqueous gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 10% wash The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Toughened silver nitrate BP 95% stick The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely povidone iodine 40 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Mupirocin (as mupirocin calcium) 20 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Mupirocin 20 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin 0.5% cream BPC The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzoyl peroxide 50 milligram/1 gram and potassium hydroxyquinoline sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Econazole nitrate 10 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Ketoconazole 20 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole nitrate 20 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole nitrate 2% dusting powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely miconazole nitrate 1.6 milligram/1 gram conventional release powder for cutaneous spray (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin 100000 unit/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin 100000 unit/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely sulconazole nitrate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely povidone iodine 50 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzalkonium chloride 100 microgram/g and cetrimide 2 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 10% ointment (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzalkonium chloride 10 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzalkonium chloride 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Brilliant green+crystal violet 0.5%/0.5% paint BP The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Crystal violet 0.5% paint BP The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Methylrosanilinium chloride 10 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hexachlorophane compound powder (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 1.14% dry powder spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 7.5% surgical scrub (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 4% skin cleanser solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 2.5% dry powder spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine antiseptic 10% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine alcoholic 10% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 10% paint The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Silver nitrate 0.5% lotion BP The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely silver nitrate 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely silver nitrate 250 milligram/1 milliliter conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely silver nitrate 400 milligram/1 milliliter conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely silver nitrate 500 milligram/1 milliliter conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Triclosan 0.5% hand rub The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Triclosan 2% bath additive The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Triclosan 2% solution (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Daptomycin 250mg injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Daptomycin 500 mg injection solution 10 mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Terbinafine hydrochloride 1% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole nitrate 200mg/2% pessary/2%cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing miconazole and tioconazole (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole 1200mg vaginal insert/miconazole 2.0% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide+miconazole nitrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing betamethasone and clioquinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Chlorhexidine hydrochloride+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasol propionate+neomycin sulfate+Nystatin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing clobetasone butyrate and neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasone butyrate+oxytetracycline+nystatin (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Compound neomycin preparations The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing clioquinol and hydrocortisone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing econazole and hydrocortisone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing hydrocortisone and miconazole (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing hydrocortisone and neomycin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone- and nystatin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing nystatin and triamcinolone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Econazole 1% preservative-free eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely framycetin sulfate 5 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole 1% preservative-free eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Framycetin sulfate 5 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Tolnaftate 10 mg/g cutaneous powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous spray (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing neomycin in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Topical neomycin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Topical tetracycline (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)

    Start Previous Page 4 of 7 Next End


    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    POSSIBLY EQUIVALENT TO association reference set

    Back to Start